Resolute Holdings Mgmt Stock (NASDAQ: RHLDV)

Latest news for Resolute Holdings Mgmt (NASDAQ:RHLDV) Stock

Resolute Holdings Management Inc is provide operating management services.

Resolute Holdings Management - Common Stock

Resolute Holdings Management Inc

Earnings

News

Guidance

FARO

FARO Technologies Sees Q1 Adj. EPS $0.10-$0.30 Vs $0.09 Est; Revenue $77M-$85M Vs $80.7M Est.

Chegg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) sees Q1 sales of $114.000 million-$116.000 million vs $138.07 million analyst estimate.

CHGG

Chegg Sees Q1 Sales $114.000M-$116.000M vs $138.07M Est

President Donald Trump reaffirmed on Monday that his administration will proceed with tariffs on imports from Canada and Mexico, despite concerns over its economic impact. The decision, initially delayed by a month, is set to take effect next week, marking a significant shift in <a href="https://www.benzinga.com/topic/tariffs">North American trade relations.</a>
What Happened: Trump reiterated his stance on tariffs at the White House press conference, claiming that foreign nations have unfairly benefited from U.S. trade policies. He emphasized the necessity of reciprocal tariffs as a corrective measure, stating, &#8220;So the tariffs will go forward, yes, and we're going to make up a lot of territory,&#8221; CNBC <a href="https://www.cnbc.com/2025/02/24/trump-says-tariffs-on-canada-and-mexico-will-go-forward.html">reported</a>.
The tariffs, covering all imported goods from Mexico and Canada, target two of the U.S.&#8217;s largest trading partners. In 2023, the U.S. imported $480 billion worth of goods from Mexico and $429.6 billion from Canada, underscoring the extensive <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/433981">economic ties between the nations.</a>
Also Read: <a href="https://www.benzinga.com/etfs/specialty-etfs/25/02/43924482/exclusive-3-etfs-positioned-for-microsofts-quantum-breakthrough">EXCLUSIVE: 3 ETFs Positioned For Microsoft&#8217;s Quantum Breakthrough</a>
Analysts warn that these tariffs could severely disrupt supply chains, particularly in the automotive and industrial sectors. Major automakers like General Motors Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) and Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) may be among the hardest hit. The added costs could lead to higher vehicle prices or force manufacturers to absorb the impact, squeezing profit margins.
Why It Matters: The economic implications could extend beyond corporate boardrooms. Goldman Sachs estimates that GDP in Canada and Mexico could decline by up to 4%, while the U.S. may experience inflationary pressure, with core personal consumption expenditures rising by 0.7%. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/25/02/43906811/trump-reportedly-warns-big-pharma-move-manufacturing-to-us-or-face-tariffs">Trump Reportedly Warns Big Pharma: Move Manufacturing To US Or Face Tariffs</a></li>
</ul>
Photo: Shutterstock

Government

Politics

Global

Trump Confirms Tariffs On Canada, Mexico Will Take Effect As Planned

Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TERN#NASDAQ">TERN</a>), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today announced the appointment of Andrew Gengos as chief financial officer, effective immediately.

Management

TERN

Terns Pharmaceuticals Appoints Andrew Gengos As Chief Financial Officer, Effective Immediately

Realty Income (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/O#NYSE">O</a>) is looking for FY2025 FFO of $4.22-$4.28 vs $4.38 analyst estimate..

Realty Income Sees FY2025 FFO $4.22-$4.28 vs $4.38 Est

EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) sees Q1 sales of $155.000 million-$160.000 million vs $136.86 million analyst estimate.

EVER

EverQuote Sees Q1 Sales $155.000M-$160.000M vs $136.86M Est

Netstreit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTST#NYSE">NTST</a>) is looking for FY2025 FFO of $1.27-$1.30 vs $1.27 analyst estimate..

NTST

Netstreit Sees FY2025 AFFO $1.27-$1.30 vs $1.27 Est

Buybacks

SONO

Sonos Announces $150M Stock Repurchase Program

Chegg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) reported quarterly earnings of $0.17 per share which met the analyst consensus estimate. This is a 52.78 percent decrease over earnings of $0.36 per share from the same period last year. The company reported quarterly sales of $143.48 million which beat the analyst consensus estimate of $142.05 million by 1.01 percent. This is a 23.67 percent decrease over sales of $187.99 million the same period last year.

Earnings Beats

Chegg Q4 Adj $0.17, Inline, Sales $143.48M Beat $142.05M Estimate

EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) reported quarterly earnings of $0.33 per share which missed the analyst consensus estimate of $0.39 by 15.38 percent. This is a 273.68 percent increase over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $147.46 million which beat the analyst consensus estimate of $133.86 million by 10.16 percent. This is a 164.71 percent increase over sales of $55.70 million the same period last year.

Earnings Misses

EverQuote Q4 EPS $0.33 Misses $0.39 Estimate, Sales $147.46M Beat $133.86M Estimate

Guidance for 20252
<ul>
<li>Revenue is estimated to be approximately $8,425 million including contribution from Environmental Services ("ES") (between $6,500 million and $6,550 million excluding contribution from ES)</li>
<li>Adjusted EBITDA2 is estimated to be approximately $2,500 million including contribution from&nbsp;ES (between $1,925 million and $1,950 million excluding contribution from ES)</li>
<li>Adjusted Free Cash Flow2 is estimated to be between $950 million and $975 million including contribution from ES (approximately $750 million excluding contribution from ES)</li>
<li>Guidance does not include contribution from any incremental M&amp;A&nbsp;</li>
</ul>

GFL Environmental Sees FY25 Revenue C$8.425B Vs C$8.37B Est.

Zoom Video Comms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) reported quarterly earnings of $1.41 per share which beat the analyst consensus estimate of $1.30 by 8.46 percent. This is a 0.7 percent decrease over earnings of $1.42 per share from the same period last year. The company reported quarterly sales of $1.18 billion which met the analyst consensus estimate. This is a 3.32 percent increase over sales of $1.15 billion the same period last year.

Zoom Video Comms Q4 2025 Adj EPS $1.41 Beats $1.30 Estimate, Sales $1.18B Inline

WIIM

BBIO

BridgeBio Pharma shares are trading lower after the company announced a $500 million proposed offering of convertible senior notes to refinance its senior secured debt.

Netstreit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTST#NYSE">NTST</a>) reported quarterly earnings of $0.32 per share which met the analyst consensus estimate. This is a 3.23 percent increase over earnings of $0.31 per share from the same period last year. The company reported quarterly sales of $44.10 million which beat the analyst consensus estimate of $41.04 million by 7.45 percent. This is a 19.64 percent increase over sales of $36.86 million the same period last year.

Netstreit Q4 AFFO $0.32, Inline, Sales $44.10M Beat $41.04M Estimate

Faro Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FARO#NASDAQ">FARO</a>) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.40 by 25 percent. This is a 38.89 percent increase over earnings of $0.36 per share from the same period last year. The company reported quarterly sales of $93.500 million which beat the analyst consensus estimate of $91.025 million by 2.72 percent. This is a 5.40 percent decrease over sales of $98.840 million the same period last year.

Faro Technologies Q4 2024 Adj. EPS $0.50 Beats $0.40 Estimate, Sales $93.500M Beat $91.025M Estimate

Offerings

BridgeBio Announces  $500M Proposed Offering Of Convertible Senior Notes To Refinance Senior Secured Debt

DMC Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOOM#NASDAQ">BOOM</a>) sees Q1 sales of $146.000 million-$154.000 million vs $145.55 million analyst estimate.

BOOM

DMC Glb Sees Q1 Sales $146.000M-$154.000M vs $145.55M Est

2025 Guidance
BWXT announced its expectations for fiscal year 2025 financial results, providing the following guidance:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">(In millions, except per share amounts)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Year Ended</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Year Ending</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">December 31, 2024</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">December 31, 2025</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Results</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Guidance(2)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Revenue</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$2,704</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">~$3,000</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA(1)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$499</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$550 - $570</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Non-GAAP(1) Earnings Per Share</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$3.33</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$3.40 - $3.55</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Free Cash Flow(1)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$255</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$265 - $285</td>
</tr>
</tbody>
</table>
</figure><figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">(2) BWXT has not included a reconciliation of provided non-GAAP guidance to comparable GAAP measures due to the difficulty of estimating any mark-to-market adjustments for pension and post-retirement benefits, which are determined at the end of the year.</td>
</tr>
</tbody>
</table>
</figure>
Additional information can be found in the 2024 fourth quarter earnings call presentation on the BWXT investor relations website at <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.bwxt.com%2F&amp;esheet=54213125&amp;newsitemid=20250224459539&amp;lan=en-US&amp;anchor=investors.bwxt.com&amp;index=2&amp;md5=b7aedb6d3a846a0f185f64cb000e7a97">investors.bwxt.com</a>. The Company does not provide GAAP guidance because it is unable to reliably forecast most of the items that are excluded from GAAP to calculate non-GAAP results. These items could cause GAAP results to differ materially from non-GAAP results.

BWXT

BWX Technologies Sees FY25 EPS $3.40-$3.55 Vs $3.43 Est.; Revenue ~$3B Vs $2.898B Est.

DMC Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOOM#NASDAQ">BOOM</a>) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $(0.29) by 131.03 percent. This is a 65.38 percent decrease over earnings of $0.26 per share from the same period last year. The company reported quarterly sales of $152.37 million which beat the analyst consensus estimate of $140.50 million by 8.45 percent. This is a 12.45 percent decrease over sales of $174.04 million the same period last year.

DMC Glb Q4 Adj $0.09 Beats $(0.29) Estimate, Sales $152.37M Beat $140.50M Estimate

Addus HomeCare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADUS#NASDAQ">ADUS</a>) reported quarterly earnings of $1.07 per share which missed the analyst consensus estimate of $1.35 by 20.74 percent. This is a 18.94 percent decrease over earnings of $1.32 per share from the same period last year. The company reported quarterly sales of $297.100 million which beat the analyst consensus estimate of $291.526 million by 1.91 percent. This is a 7.51 percent increase over sales of $276.351 million the same period last year.

Comments

Resolute Holdings Mgmt

News

Latest news for Resolute Holdings Mgmt (NASDAQ:RHLDV) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga